Hepatic Encephalopathy: Overcoming Caregiver Guilt and Stigma

Caregiver advocate Young is partnering with Salix Pharmaceuticals to raise awareness about Hepatic Encephalopathy (HE) after her father died from the condition in 1985. Young aims to reduce the stigma and isolation associated with liver disease, noting that shame regarding her father’s drinking delayed the identification of his HE.

How does stigma affect Hepatic Encephalopathy care?

Shame surrounding the causes of liver disease can lead families to isolate themselves. According to Young, her family experienced significant shame because her father’s illness stemmed from drinking.

This isolation prevented the family from reaching out for support. Young suggests that seeking help may have helped them identify the HE earlier and could have alleviated the burden of caregiving.

Did You Know? Young’s father passed away in 1985 due to complications resulting from Hepatic Encephalopathy.

What was the impact of HE on family dynamics?

Young describes herself as a reluctant caregiver during her teenage years. She recalls feeling angry that she could not participate in “normal” teen activities, such as going on dates or having friends over, because her father was in a hospital bed in their living room.

At the time, Young blamed her father for his condition. Through therapy, she now understands her behavior was a reaction to the fear of losing him. She notes that while she can now separate the man from the disease, she was “at [her] jerkiest” as a teenager.

Expert Insight: Samantha Carter suggests that the intersection of adolescent development and chronic illness creates a high-stress environment. When stigma is added to this mix, it may create a cycle of isolation that complicates both the medical management of the patient and the emotional recovery of the caregiver.

What is the goal of the current HE awareness partnership?

Young has partnered with Salix Pharmaceuticals, the manufacturer of the HE drug rifaximin (Xifaxan), to facilitate open conversations. The partnership focuses on patients and caregivers living with HE.

The mission is to expand public knowledge of the disease. Young states that there is no point in adding hardship to the disease by allowing patients or caregivers to feel ashamed or alone.

What may happen next for HE advocacy?

Increased open dialogue about the causes of liver disease may lead to earlier identification of HE in other families. This shift in approach could potentially reduce the emotional burden on young caregivers by normalizing the support process.

Frequently Asked Questions

What is the goal of Young’s partnership with Salix Pharmaceuticals?
The partnership aims to raise awareness of HE and have honest, open conversations with patients and caregivers to ensure they know they are not alone.

How did stigma impact Young’s family?
Because the illness was linked to drinking, the family felt shame, which caused them to isolate themselves rather than seek support.

What drug does Salix Pharmaceuticals manufacture for HE?
Salix Pharmaceuticals manufactures the HE drug rifaximin, known as Xifaxan.

How can communities better support family caregivers dealing with stigmatized illnesses?